MedPath

Autonomic and Metabolic Response to Cardiac Rehabilitation After Acute MI

Recruiting
Conditions
Acute Myocardial Infarction: Rehabilitation Phase
Registration Number
NCT06298513
Lead Sponsor
Istituto Auxologico Italiano
Brief Summary

Ischemic heart disease remains the leading cause of death in the western world. The beneficial effects of cardiac rehabilitation on the evolution of ischemic heart disease are known, but the effects of rehabilitation on the metabolic processes of the patients are so far poorly understood. Metabolomics is the qualitative/quantitative analysis of the body's metabolic responses to pathophysiological stimuli or genetic alterations. Metabolic changes caused by physical activity have been demonstrated in obese and diabetic patients and in athletes. Aim of the study is to evaluate whether cardiac rehabilitation after a first myocardial infarction induces changes in the metabolic state of patients, and whether these changes may be related with changes in the usual risk factors (i.e. glyco-lipidic profile, natriuretic peptides, homocysteine).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
25
Inclusion Criteria
  • recent first acute myocardial infarction
Exclusion Criteria
  • severe diabetes

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in purine after rehabilitationBaseline and after 6 weeks of rehabilitation

The concentration of purine will be calculated after rehabilitation, and compared to its baseline concentration by a paired T test analysis.

Changes in histidine after rehabilitationBaseline and after 6 weeks of rehabilitation

The concentration of purine will be calculated after rehabilitation, and compared to its baseline concentration by a paired T test analysis

Changes in galactose after rehabilitationBaseline and after 6 weeks of rehabilitation

The concentration of galactose will be calculated after rehabilitation, and compared to its baseline concentration by a paired T test analysis.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Istituto Auxologico Italiano

🇮🇹

Milan, Italy

Istituto Auxologico Italiano
🇮🇹Milan, Italy
Lia Crotti, MD PhD
Contact
39 0261911
lia.crotti@unimib.it

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.